Fred Hutchinson Cancer Center12h
Drs. Keith Jerome and Jesse Bloom elected fellows of American Academy of Microbiology
Fred Hutch virologist Keith Jerome, MD, PhD, and evolutionary biologist Jesse Bloom, PhD, were recently elected to the 2025 ...
AZoLifeSciences on MSN14h
New Insights into How B Cells Strategically Clone High-Affinity Antibodies
A vaccine's ability to generate long-lasting, high-affinity antibodies hinges on a delicate balance. Upon exposure to a vaccine or pathogen, B cells scramble to refine their defenses, rapidly mutating ...
Upgraded CRISPR tool enables more seamless gene editing and improved disease modeling
Advances in the gene-editing technology known as CRISPR-Cas9 over the past 15 years have yielded important new insights into ...
Managed Healthcare Executive10h
FDA Approves First-Ever Cell Therapy Treatment for Rare Progressive Eye Disease
Encelto is small, semi-permeable capsule implanted in the eye that contains allogeneic retinal pigment epithelium cells ...
National Institute for Health and Care Excellence17h
In consultation: Guidance and quality standards
Natalizumab (originator and biosimilar) for treating highly active relapsing–remitting multiple sclerosis after disease-modifying therapy [ID6369] Draft guidance Technology appraisal guidance 2 April ...
Johns Hopkins Medicine11h
HIV and AIDS
AIDS (acquired immunodeficiency syndrome) is caused by the human immunodeficiency virus (HIV). This kills or impairs cells of the immune system and progressively destroys the body's ability to fight ...